(Q33841438)

English

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

2

object named as

Sergio Giralt

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

object named as

Chitra Hosing

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

object named as

Uday Popat

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

object named as

Rima Saliba

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Richard E Champlin

16

object named as

Richard E Champlin

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

object named as

Issa Khouri

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Muzaffar Qazilbash

8

object named as

Muzaffar Qazilbash

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shubhra Ghosh Dastidar

11

object named as

Shubhra Ghosh

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

15

object named as

Michele Donato

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Partow Kebriaei

10

object named as

Partow Kebriaei

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

object named as

Betul Oran

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Antonio Carrasco-Yalan

12

object named as

Antonio Carrasco-Yalan

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Daniel Couriel

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paolo Anderlini

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ernesto de Meis

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Marcos de Lima

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Athanasios Anagnostopoulos

14

0 references

publication date

8 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

454-462

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Risk factors and their relationship to prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Development of a single probe for documentation of chimerism following bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

5 July 2018

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

29 October 2018

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

29 October 2018

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

29 October 2018

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

29 October 2018

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4080636

29 October 2018

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17382251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2006.11.024

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33841438&oldid=1919943122"